Serveur d'exploration sur les pandémies grippales

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

N-acetyl-L-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus

Identifieur interne : 000413 ( Hal/Corpus ); précédent : 000412; suivant : 000414

N-acetyl-L-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus

Auteurs : Janina Geiler ; Martin Michaelis ; Patrizia Naczk ; Anke Leutz ; Klaus Langer ; Hans-Wilhelm Doerr ; Jindrich Cinatl

Source :

RBID : Hal:hal-00538093

Abstract

The antioxidant N-acetyl-L-cysteine (NAC) had been shown to inhibit replication of seasonal human influenza A viruses. Here, the effects of NAC on virus replication, virus-induced pro-inflammatory responses and virus-induced apoptosis were investigated in H5N1-infected lung epithelial (A549) cells. NAC at concentrations ranging from 5 to 15mM reduced H5N1-induced cytopathogenic effects (CPE), virus-induced apoptosis and infectious viral yields 24hours post-infection. NAC also decreased the production of pro-inflammatory molecules (CXCL8, CXCL10, CCL5, interleukin-6 (IL-6)) in H5N1-infected A549 cells and reduced monocyte migration towards supernatants of H5N1-infected A549 cells. The antiviral and anti-inflammatory mechanisms of NAC included inhibition of activation of oxidant sensitive pathways including transcription factor NF-κB and mitogen activated protein kinase p38. Pharmacological inhibitors of NF-κB (BAY 11-7085) or p38 (SB203580) exerted similar effects like those determined for NAC in H5N1-infected cells. The combination of BAY 11-7085 and SB203580 resulted in increased inhibitory effects on virus replication and production of pro-inflammatory molecules relative to either single treatment. NAC inhibits H5N1 replication and H5N1-induced production of pro-inflammatory molecules. Therefore, antioxidants like NAC represent a potential additional treatment option that could be considered in the case of an influenza A virus pandemic.


Url:
DOI: 10.1016/j.bcp.2009.08.025

Links to Exploration step

Hal:hal-00538093

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">N-acetyl-L-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus</title>
<author>
<name sortKey="Geiler, Janina" sort="Geiler, Janina" uniqKey="Geiler J" first="Janina" last="Geiler">Janina Geiler</name>
</author>
<author>
<name sortKey="Michaelis, Martin" sort="Michaelis, Martin" uniqKey="Michaelis M" first="Martin" last="Michaelis">Martin Michaelis</name>
</author>
<author>
<name sortKey="Naczk, Patrizia" sort="Naczk, Patrizia" uniqKey="Naczk P" first="Patrizia" last="Naczk">Patrizia Naczk</name>
</author>
<author>
<name sortKey="Leutz, Anke" sort="Leutz, Anke" uniqKey="Leutz A" first="Anke" last="Leutz">Anke Leutz</name>
</author>
<author>
<name sortKey="Langer, Klaus" sort="Langer, Klaus" uniqKey="Langer K" first="Klaus" last="Langer">Klaus Langer</name>
</author>
<author>
<name sortKey="Doerr, Hans Wilhelm" sort="Doerr, Hans Wilhelm" uniqKey="Doerr H" first="Hans-Wilhelm" last="Doerr">Hans-Wilhelm Doerr</name>
</author>
<author>
<name sortKey="Cinatl, Jindrich" sort="Cinatl, Jindrich" uniqKey="Cinatl J" first="Jindrich" last="Cinatl">Jindrich Cinatl</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">HAL</idno>
<idno type="RBID">Hal:hal-00538093</idno>
<idno type="halId">hal-00538093</idno>
<idno type="halUri">https://hal.archives-ouvertes.fr/hal-00538093</idno>
<idno type="url">https://hal.archives-ouvertes.fr/hal-00538093</idno>
<idno type="doi">10.1016/j.bcp.2009.08.025</idno>
<date when="2009-11-21">2009-11-21</date>
<idno type="wicri:Area/Hal/Corpus">000413</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">N-acetyl-L-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus</title>
<author>
<name sortKey="Geiler, Janina" sort="Geiler, Janina" uniqKey="Geiler J" first="Janina" last="Geiler">Janina Geiler</name>
</author>
<author>
<name sortKey="Michaelis, Martin" sort="Michaelis, Martin" uniqKey="Michaelis M" first="Martin" last="Michaelis">Martin Michaelis</name>
</author>
<author>
<name sortKey="Naczk, Patrizia" sort="Naczk, Patrizia" uniqKey="Naczk P" first="Patrizia" last="Naczk">Patrizia Naczk</name>
</author>
<author>
<name sortKey="Leutz, Anke" sort="Leutz, Anke" uniqKey="Leutz A" first="Anke" last="Leutz">Anke Leutz</name>
</author>
<author>
<name sortKey="Langer, Klaus" sort="Langer, Klaus" uniqKey="Langer K" first="Klaus" last="Langer">Klaus Langer</name>
</author>
<author>
<name sortKey="Doerr, Hans Wilhelm" sort="Doerr, Hans Wilhelm" uniqKey="Doerr H" first="Hans-Wilhelm" last="Doerr">Hans-Wilhelm Doerr</name>
</author>
<author>
<name sortKey="Cinatl, Jindrich" sort="Cinatl, Jindrich" uniqKey="Cinatl J" first="Jindrich" last="Cinatl">Jindrich Cinatl</name>
</author>
</analytic>
<idno type="DOI">10.1016/j.bcp.2009.08.025</idno>
<series>
<title level="j">Biochemical Pharmacology</title>
<idno type="ISSN">0006-2952</idno>
<imprint>
<date type="datePub">2009-11-21</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="mix" xml:lang="lt">
<term>H5N1</term>
<term>NAC</term>
<term>ROS</term>
<term>apoptosis</term>
<term>cytokines</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>The antioxidant N-acetyl-L-cysteine (NAC) had been shown to inhibit replication of seasonal human influenza A viruses. Here, the effects of NAC on virus replication, virus-induced pro-inflammatory responses and virus-induced apoptosis were investigated in H5N1-infected lung epithelial (A549) cells. NAC at concentrations ranging from 5 to 15mM reduced H5N1-induced cytopathogenic effects (CPE), virus-induced apoptosis and infectious viral yields 24hours post-infection. NAC also decreased the production of pro-inflammatory molecules (CXCL8, CXCL10, CCL5, interleukin-6 (IL-6)) in H5N1-infected A549 cells and reduced monocyte migration towards supernatants of H5N1-infected A549 cells. The antiviral and anti-inflammatory mechanisms of NAC included inhibition of activation of oxidant sensitive pathways including transcription factor NF-κB and mitogen activated protein kinase p38. Pharmacological inhibitors of NF-κB (BAY 11-7085) or p38 (SB203580) exerted similar effects like those determined for NAC in H5N1-infected cells. The combination of BAY 11-7085 and SB203580 resulted in increased inhibitory effects on virus replication and production of pro-inflammatory molecules relative to either single treatment. NAC inhibits H5N1 replication and H5N1-induced production of pro-inflammatory molecules. Therefore, antioxidants like NAC represent a potential additional treatment option that could be considered in the case of an influenza A virus pandemic.</p>
</div>
</front>
</TEI>
<hal api="V3">
<titleStmt>
<title xml:lang="en">N-acetyl-L-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus</title>
<author role="aut">
<persName>
<forename type="first">Janina</forename>
<surname>Geiler</surname>
</persName>
<idno type="halauthorid">547269</idno>
</author>
<author role="aut">
<persName>
<forename type="first">Martin</forename>
<surname>Michaelis</surname>
</persName>
<idno type="halauthorid">547226</idno>
</author>
<author role="aut">
<persName>
<forename type="first">Patrizia</forename>
<surname>Naczk</surname>
</persName>
<idno type="halauthorid">549223</idno>
</author>
<author role="aut">
<persName>
<forename type="first">Anke</forename>
<surname>Leutz</surname>
</persName>
<idno type="halauthorid">549224</idno>
</author>
<author role="aut">
<persName>
<forename type="first">Klaus</forename>
<surname>Langer</surname>
</persName>
<idno type="halauthorid">549225</idno>
</author>
<author role="aut">
<persName>
<forename type="first">Hans-Wilhelm</forename>
<surname>Doerr</surname>
</persName>
<idno type="halauthorid">549226</idno>
</author>
<author role="crp">
<persName>
<forename type="first">Jindrich</forename>
<surname>Cinatl</surname>
</persName>
<email type="md5">3e039be0ba83a5dd992f59ce23acd0bf</email>
<email type="domain">em.uni-frankfurt.de</email>
<idno type="halauthorid">547228</idno>
</author>
<editor role="depositor">
<persName>
<forename>Hal</forename>
<surname>Peer</surname>
</persName>
<email type="md5">86d0524708364ec39d879b6988476a91</email>
<email type="domain">inria.fr</email>
</editor>
</titleStmt>
<editionStmt>
<edition n="v1" type="current">
<date type="whenSubmitted">2010-11-21 02:50:28</date>
<date type="whenWritten">2009-06-16</date>
<date type="whenModified">2019-07-23 09:30:03</date>
<date type="whenReleased">2010-11-21 02:50:28</date>
<date type="whenProduced">2009-11-21</date>
<date type="whenEndEmbargoed">2010-11-21</date>
<ref type="file" target="https://hal.archives-ouvertes.fr/hal-00538093/document">
<date notBefore="2010-11-21"></date>
</ref>
<ref type="file" subtype="author" n="1" target="https://hal.archives-ouvertes.fr/hal-00538093/file/PEER_stage2_10.1016%252Fj.bcp.2009.08.025.pdf">
<date notBefore="2010-11-21"></date>
</ref>
<ref type="externalLink" target="https://hal.archives-ouvertes.fr/hal-00538093/document"></ref>
</edition>
<respStmt>
<resp>contributor</resp>
<name key="148147">
<persName>
<forename>Hal</forename>
<surname>Peer</surname>
</persName>
<email type="md5">86d0524708364ec39d879b6988476a91</email>
<email type="domain">inria.fr</email>
</name>
</respStmt>
</editionStmt>
<publicationStmt>
<distributor>CCSD</distributor>
<idno type="halId">hal-00538093</idno>
<idno type="halUri">https://hal.archives-ouvertes.fr/hal-00538093</idno>
<idno type="halBibtex">geiler:hal-00538093</idno>
<idno type="halRefHtml">Biochemical Pharmacology, Elsevier, 2009, 79 (3), pp.413. ⟨10.1016/j.bcp.2009.08.025⟩</idno>
<idno type="halRef">Biochemical Pharmacology, Elsevier, 2009, 79 (3), pp.413. ⟨10.1016/j.bcp.2009.08.025⟩</idno>
</publicationStmt>
<seriesStmt>
<idno type="stamp" n="PEER">PEER Publishing and the Ecology of European Research</idno>
</seriesStmt>
<notesStmt>
<note type="audience" n="2">International</note>
<note type="popular" n="0">No</note>
<note type="peer" n="1">Yes</note>
</notesStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">N-acetyl-L-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus</title>
<author role="aut">
<persName>
<forename type="first">Janina</forename>
<surname>Geiler</surname>
</persName>
<idno type="halauthorid">547269</idno>
</author>
<author role="aut">
<persName>
<forename type="first">Martin</forename>
<surname>Michaelis</surname>
</persName>
<idno type="halauthorid">547226</idno>
</author>
<author role="aut">
<persName>
<forename type="first">Patrizia</forename>
<surname>Naczk</surname>
</persName>
<idno type="halauthorid">549223</idno>
</author>
<author role="aut">
<persName>
<forename type="first">Anke</forename>
<surname>Leutz</surname>
</persName>
<idno type="halauthorid">549224</idno>
</author>
<author role="aut">
<persName>
<forename type="first">Klaus</forename>
<surname>Langer</surname>
</persName>
<idno type="halauthorid">549225</idno>
</author>
<author role="aut">
<persName>
<forename type="first">Hans-Wilhelm</forename>
<surname>Doerr</surname>
</persName>
<idno type="halauthorid">549226</idno>
</author>
<author role="crp">
<persName>
<forename type="first">Jindrich</forename>
<surname>Cinatl</surname>
</persName>
<email type="md5">3e039be0ba83a5dd992f59ce23acd0bf</email>
<email type="domain">em.uni-frankfurt.de</email>
<idno type="halauthorid">547228</idno>
</author>
</analytic>
<monogr>
<idno type="halJournalId" status="VALID">11103</idno>
<idno type="issn">0006-2952</idno>
<idno type="eissn">1873-2968</idno>
<title level="j">Biochemical Pharmacology</title>
<imprint>
<publisher>Elsevier</publisher>
<biblScope unit="volume">79</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="pp">413</biblScope>
<date type="datePub">2009-11-21</date>
</imprint>
</monogr>
<idno type="doi">10.1016/j.bcp.2009.08.025</idno>
</biblStruct>
</sourceDesc>
<profileDesc>
<langUsage>
<language ident="en">English</language>
</langUsage>
<textClass>
<keywords scheme="author">
<term xml:lang="lt">ROS</term>
<term xml:lang="lt">NAC</term>
<term xml:lang="lt">cytokines</term>
<term xml:lang="lt">H5N1</term>
<term xml:lang="lt">apoptosis</term>
</keywords>
<classCode scheme="halTypology" n="ART">Journal articles</classCode>
</textClass>
<abstract xml:lang="en">
<p>The antioxidant N-acetyl-L-cysteine (NAC) had been shown to inhibit replication of seasonal human influenza A viruses. Here, the effects of NAC on virus replication, virus-induced pro-inflammatory responses and virus-induced apoptosis were investigated in H5N1-infected lung epithelial (A549) cells. NAC at concentrations ranging from 5 to 15mM reduced H5N1-induced cytopathogenic effects (CPE), virus-induced apoptosis and infectious viral yields 24hours post-infection. NAC also decreased the production of pro-inflammatory molecules (CXCL8, CXCL10, CCL5, interleukin-6 (IL-6)) in H5N1-infected A549 cells and reduced monocyte migration towards supernatants of H5N1-infected A549 cells. The antiviral and anti-inflammatory mechanisms of NAC included inhibition of activation of oxidant sensitive pathways including transcription factor NF-κB and mitogen activated protein kinase p38. Pharmacological inhibitors of NF-κB (BAY 11-7085) or p38 (SB203580) exerted similar effects like those determined for NAC in H5N1-infected cells. The combination of BAY 11-7085 and SB203580 resulted in increased inhibitory effects on virus replication and production of pro-inflammatory molecules relative to either single treatment. NAC inhibits H5N1 replication and H5N1-induced production of pro-inflammatory molecules. Therefore, antioxidants like NAC represent a potential additional treatment option that could be considered in the case of an influenza A virus pandemic.</p>
</abstract>
</profileDesc>
</hal>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Hal/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000413 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Hal/Corpus/biblio.hfd -nk 000413 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    Hal
   |étape=   Corpus
   |type=    RBID
   |clé=     Hal:hal-00538093
   |texte=   N-acetyl-L-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021